Inhibition of ADAMTS-5: the right target for osteoarthritis?
Osteoarthritis Cartilage
.
2022 Feb;30(2):175-177.
doi: 10.1016/j.joca.2021.09.012.
Epub 2021 Oct 6.
Authors
A Latourte
1
,
P Richette
2
Affiliations
1
Université de Paris, INSERM, UMR-S 1132 BIOSCAR, F-75010, Paris, France; Rheumatology Department, AP-HP, Lariboisière Hospital, F-75010, Paris, France. Electronic address: augustin.latourte@aphp.fr.
2
Université de Paris, INSERM, UMR-S 1132 BIOSCAR, F-75010, Paris, France; Rheumatology Department, AP-HP, Lariboisière Hospital, F-75010, Paris, France.
PMID:
34624506
DOI:
10.1016/j.joca.2021.09.012
No abstract available
Publication types
Editorial
MeSH terms
ADAMTS5 Protein / antagonists & inhibitors*
Humans
Osteoarthritis / drug therapy*
Substances
ADAMTS5 Protein